NASDAQ:RLAY

Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June
····

Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June

Relay Therapeutics shares traded at $14.50 Thursday, holding above last week’s $12 public offering price after raising $296.8 million from a stock sale. The company reported early Phase 2 data showing 60% of evaluable patients with PIK3CA-driven vascular anomalies responded to its drug zovegalisib. Management will present at two major healthcare conferences in June. Relay ended Q1 with $642.1 million in cash.
May 28, 2026

Stock Market Today

  • UK Stocks Fall Amid US-Iran Tensions and Mixed Corporate Earnings
    May 28, 2026, 12:34 PM EDT. The UK's FTSE 100 dropped 0.75% due to renewed US-Iran conflict after missile strikes raised oil prices and inflation concerns. SSE reported fiscal 2026 earnings growth, increased dividends, and a 20% rise in capital investment, mainly in electricity transmission, but shares fell 1.03%. Johnson Matthey logged a loss for the year ended March 2026, keeping dividend steady and expects modest profit growth in 2027; shares slipped 0.18%. The company also agreed to acquire US catalyst maker Cormetech for $360 million, pending approval. UK vehicle output fell 1.2% year-on-year in April, with exports up 0.8%, signaling stabilization at lower production levels, according to the Society of Motor Manufacturers and Traders.